New immune-stimulating drug, with chemo, shrinks pancreas tumors

The results of an early-stage (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to new data. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail